In the subgroup with pre-existing DM2, the time interval until the diagnosis of HCC was longer in insulin treated patients than in those treated with antidiabetic oral agents (171.5 ± 87.6 versus 118.7 ± 95.2 months; P < 0.05) (Table 5). Here, INS is linked to hepatocellular carcinoma.